Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The tuberculosis diagnostics market has been witnessing significant advancement, driven by the critical need for timely and precise detection of tuberculosis infections worldwide. As healthcare systems prioritize early diagnosis and treatment, the market is set to experience robust growth in the coming years. Here is a detailed overview of the current market landscape, its growth factors, leading companies, and emerging trends shaping its future.

Steady Growth Outlook for the Tuberculosis Diagnostics Market

The tuberculosis diagnostics industry has seen notable expansion in recent years, with its market size expected to rise from $2.34 billion in 2025 to $2.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.9%. Looking ahead, the market is projected to reach $3.37 billion by 2030, growing at a CAGR of 7.5%. This upward trajectory is largely fueled by a combination of factors including the global tuberculosis burden, the expansion of public health screening initiatives, widespread availability of smear microscopy facilities, international funding for tuberculosis control, and the increasing adoption of culture-based diagnostic techniques.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Key Factors Accelerating Tuberculosis Diagnostics Market Expansion

One of the primary drivers behind the tuberculosis diagnostics market growth is the rising incidence of tuberculosis worldwide. Tuberculosis, a contagious bacterial infection mainly affecting the lungs, requires prompt detection to reduce complications and halt transmission. The increasing prevalence of HIV/AIDS, which compromises immune defenses, significantly contributes to the heightened susceptibility to active tuberculosis infections. This has created an urgent need for rapid, accurate, and point-of-care diagnostic solutions that support early treatment and effective disease management.

Recent data underscores this trend. For example, in October 2025, the UK Health Security Agency reported a 13.6 percent rise in tuberculosis cases in England during 2024 compared to the previous year, with 5,490 notifications in 2024 versus 4,831 in 2023. This surge in TB cases is directly influencing the demand and growth of the tuberculosis diagnostics market globally.

Access The Complete Tuberculosis Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Detailed Segmentation and Growth Potential in Tuberculosis Diagnostics

The report segments the tuberculosis diagnostics market in several ways to provide comprehensive insight:

1) By Test Type: including Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, and Other Test Types.

2) By Disease Stage: categorized into Latent Tuberculosis and Active Tuberculosis.

3) By End-User: covering Hospitals and Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, and Academic and Research Institutions.

Further breakdown includes specific test types such as Chest X-rays and CT Scans under Radiographic Tests; Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Tests (NAATs) under Nucleic Acid Testing; Interferon Gamma Release Assays (IGRAs) for Cytokine Detection; GeneXpert MTB/RIF and Line Probe Assays for Drug Resistance; Tuberculin Skin Test (TST) under Skin Test; Serological Tests for Blood or Serology; Acid-Fast Bacilli (AFB) Smear Test in Smear Microscopy; Solid and Liquid Media Cultures under Cell Culture-Based Tests; and other molecular and advanced imaging tests.

Innovations and Trends Shaping Tuberculosis Diagnostics Industry Growth

Leading players in this market are heavily investing in innovative product development to enhance tuberculosis diagnostic capabilities. These advancements focus on creating fast, reliable, and comprehensive testing solutions that can identify active TB, latent infections, and drug-resistant strains to ensure timely and targeted treatment. For example, in February 2023, Redcliffe Labs in India introduced the BD MAX MDR TB test, performed on the BD MAX molecular diagnostic system. This test allows clinicians to rapidly detect tuberculosis bacteria along with mutations linked to resistance against key first-line drugs, Isoniazid (INH) and Rifampicin (RIF), facilitating quicker clinical decision-making.

Major Industry Participants Competing in the Tuberculosis Diagnostics Market

The tuberculosis diagnostics sector features several prominent companies, including Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V., BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd., Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, and BixBio. These companies focus on expanding their product portfolios and strengthening their market positions through research and innovation.

Regional Market Leadership and Emerging Areas of Growth

In 2025, the Asia-Pacific region emerged as the largest market for tuberculosis diagnostics. The broader geographic scope considered in the market analysis includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. While Asia-Pacific currently leads in market share, other regions continue to demonstrate potential growth opportunities due to the rising tuberculosis burden and healthcare infrastructure improvements.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model